


Angiotech Pharmaceuticals, Inc. announces financial results for the second ... PR Newswire (press release) Enrolled patients received MultiStem delivered via a catheter into the damaged region of the heart 2-5 days following percutaneous coronary intervention ... |
BUYINS.NET: (EW) SqueezeTrigger Price is $54.245. There is $330134846.00 That ... Trading Markets (press release) Edwards Lifesciences is developing percutaneous heart valve repair and replacement technologies, designed to treat heart valve disease using a ... |
Radical CVD strategy for next decade Irish Medical Times The focus of cardiac care in hospitals will be on acute coronary syndrome and managing patients through percutaneous coronary intervention (PCI). ... |